Immune system - indirect, paracrine modulation via secreted factors

Immune system - indirect, paracrine modulation via secreted factors is a descriptive classification for a biological process and pharmacological mechanism rather than a specific molecular target. This process involves the secretion of signaling molecules, such as cytokines and chemokines, by one cell to influence the activity of neighboring cells within the local environment (Alberts et al., Molecular Biology of the Cell, 2014). In the immune system, paracrine signaling is essential for coordinating responses between different cell types, such as macrophages activating T-cells via interleukin secretion (Janeway's Immunobiology, 9th Ed). Dysregulation of these secreted factors is a hallmark of many diseases, including chronic inflammation, autoimmune disorders, and the establishment of an immunosuppressive tumor microenvironment (Nature Reviews Immunology, 2018). Drugs that utilize this mechanism do not target a single receptor but rather intervene in the signaling cascade by neutralizing secreted ligands or blocking their respective receptors on adjacent cells. Examples include TNF-alpha inhibitors like infliximab and IL-6 receptor antagonists like tocilizumab, which effectively dampen systemic and local inflammatory responses (PubChem). Because this term encompasses a wide variety of distinct proteins and pathways, it is considered a functional category or mechanism of action rather than a discrete therapeutic target.

Other names

Paracrine immune signalingIndirect immune regulationSecreted factor-mediated immune modulationCytokine-mediated paracrine signaling

Modulation of the immune microenvironment through the neutralization of secreted signaling molecules or the blockade of their receptors on neighboring cells.